McNicoll Lewis & Vlak Starts Alnylam Pharmaceuticals (ALNY) at Buy; Investing in the Next Leap of Human Therapeutics with RNA Interference (RNAi)
Go back to McNicoll Lewis & Vlak Starts Alnylam Pharmaceuticals (ALNY) at Buy; Investing in the Next Leap of Human Therapeutics with RNA Interference (RNAi)| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 228.65 +1.53 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.12 | 52 Week High | $109.10 | |||
| Open | $223.52 | 52 Week Low | $31.38 | |||
| Day High | $228.98 | P/E | N/A | |||
| Day Low | $220.23 | EPS | $-1.45 | |||
| Volume | 1,525,924 | |||||
